Company / Revenue
BioAge Labs, Inc. Revenue History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$9.0M
FY2025
5-year range
$9.0M / $9.0M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#138 of 155
Health Care
What the data says
BioAge Labs, Inc.'s revenue of $9M is lower than 89% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$9M in FY2025.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 155This company $9.0M Sector average $4.5B
▼
-99.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.0M | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026